Category:
Respiratory System Drugs
CAS NO:
1421373-65-0
Standard:
In-house Standards,
AZD-9291
CAS NO: 1421373-65-0
MF: C28H33N7O2
MW: 499.61
Orally bioavailable mutant-selective EGFR inhibitor that has been tested in Phase III clinical trials for treatment of Non-Small Cell Lung Cancer